TABLE 1.
Demographic and laboratory criteria and hepatitis E virus (HEV) and non-HEV suspected drug-induced liver injury (DILI).
| HEV suspected DILI N = 12 | Non-HEV suspected DILI N = 68 | Statisticsa S/NS | |
| Age (years) | 50 (40–64) | 43 (32–52) | P = 0.09, NS |
| Sex (M/F) Ratio | 7/5 1.4:1 | 38/30 1.26:1 | P = 0.99, NS |
| ALT U/L | 550 (458–847) | 321 (280–394) | P < 0.0001, S |
| ALP U/L | 290 (199–350) | 314 (239–354) | P = 0.46, NS |
| R-valueb | 6.6 (4.3–8.0) | 2.96 (2.62–3.97) | P < 0.0001, S |
| AST U/L | 462 (348–718) | 274 (215–318) | P < 0.0001, S |
| Bilirubin (μmol/L) | 143 (115–188) | 134 (111–174) | P = 0.36, NS |
| Esinophilia (% positive) | 3/12 (25%) | 22/68 (32.3%) | P = 0.74, NS |
All values are represented as medians and interquartile ranges. ALT: normal range < 40 U/L; AST: normal range < 35 U/L, and ALP: normal range, 46–115 U/L; bilirubin:
normal range 1.71 to 20.5 μmol/L.
S, significant; NS, non-significant.
aStatistics was calculated using Mann–Whitney test.
bR-value = (ALT/ULN)/(ALP/ULN). ULN is the upper limit of normal. The ULN of ALT and ALP was set as 40 and 115 U/L, respectively.